Kali Inc. (KALY)

[pyro2]

I think KALY shines above the other contenders in that USMJ mess, IMO. A short squeeze should contribute to higher numbers in KALY too. The short sales reported by FINRA exceeded 60% of total volume of KALY.

It has the potential to run to .04. and .10 in the near term. Shortly after the 2018 Q4 acquisition of the patented cannabis extraction process, the company PPS shot from sub-penny land to almost $0.04 on volume that put it in the top 20 most actively traded stocks on the OTC Market.

With KALY’s patented cannabis pharmaceutical research now coming to light, the price is positioned to shoot past the recent $0.04 highs to a level putting it on par with some of the other penny cannabis stock contenders. A 10 cent price is not unreasonable following .04 and the company filing its upcoming annual reported expected to include the company posting its first revenue derived from its cannabis extraction process.

Plus KALY is providing CBD extracts for over $1 million worth of CBD infused water produced by Puration, Inc. (USOTC: PURA), and KALY has also introduced its own CBD infused gum.

KALY is also implementing an extraction lab to process biomass from Nouveau’s (USOTC: NOUV) 100 acer hemp farm.

And of course, the recent news on the four potential health related products; COPD, Type 2 Diabetes, Cancer Pain Management and the forth to be announced this week.